Stocks are off to a mixed start on Wall Street as losses for Big Tech companies offset gains elsewhere in the market. The S&P ...

The retailer’s exclusive deal to sell Swift’s self-published Eras Tour book could brighten an otherwise rough run for Target.

Edward Scolnick led the development of dozens of medicines while at Merck. His current mission pits him against time and the ...